Compare SXC & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SXC | THW |
|---|---|---|
| Founded | 1960 | N/A |
| Country | United States | United States |
| Employees | 848 | N/A |
| Industry | Steel/Iron Ore | Finance Companies |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 555.4M | 513.9M |
| IPO Year | 2011 | 2015 |
| Metric | SXC | THW |
|---|---|---|
| Price | $6.25 | $12.67 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 82.9K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 7.67% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,600,300,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.30 | N/A |
| 52 Week Low | $5.52 | $10.10 |
| 52 Week High | $9.82 | $13.19 |
| Indicator | SXC | THW |
|---|---|---|
| Relative Strength Index (RSI) | 46.60 | 62.86 |
| Support Level | $6.24 | $12.33 |
| Resistance Level | $6.90 | $12.95 |
| Average True Range (ATR) | 0.21 | 0.28 |
| MACD | -0.00 | 0.13 |
| Stochastic Oscillator | 27.20 | 92.86 |
SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is mainly used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through two segments: Domestic Coke and Industrial Services. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal-producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.